肿瘤疾病治疗再添“医联体”生力军

2017-07-17 佚名 新浪医药新闻

7月15日,由中国医院协会、中国健康促进基金会、全国卫生产业企业管理协会主办,全国卫生产业企业管理协会医联体分会、中国健康促进基金会医联体专项基金管理委员会、北京远程视界集团、首都医疗集团、微医集团承办,国家卫生和计划生育委员会医政医管局、国家卫生计生委医疗管理服务指导中心、国家卫生计生委医院管理研究所指导的“2017全国医联体建设与发展论坛”在国家会议中心正式召开。

7月15日,由中国医院协会、中国健康促进基金会、全国卫生产业企业管理协会主办,全国卫生产业企业管理协会医联体分会、中国健康促进基金会医联体专项基金管理委员会、北京远程视界集团、首都医疗集团、微医集团承办,国家卫生和计划生育委员会医政医管局、国家卫生计生委医疗管理服务指导中心、国家卫生计生委医院管理研究所指导的“2017全国医联体建设与发展论坛”在国家会议中心正式召开。

下午,平行分论坛中国医院协会传染病医院管理分会全国肝病医联体、放疗医联体、病理医联体 成立。大会邀请北京佑安医院院长,中国医院协会传染病医院管理分会主任委员李宁担任医联体分会会长。同时邀请行业领袖和各领域最顶尖专家担任医联体主席,并就各自研究领域做专题学术报告。



为放疗医联体主席、病理医联体主席授予聘书

会上,李宁教授、陈杰教授、王俊杰教授、卢朝辉教授、李永进理事长、乔宝龙秘书长、陈峰总裁共同开启了“全国卫生产业企业管理协会医联体分会全国肝病医联体、病理医联体、放疗医联体,一带一路肿瘤精准放疗与微创治疗战略发展联盟、肿瘤精准化诊疗专项基金启动仪式”,并为到场的部分基地医院进行每家医院100万元专项基金的捐赠和授牌。



肿瘤精准化诊疗专项基金启动仪式



肿瘤精准化诊疗专项基金授牌仪式

群英荟萃同台演讲

全国卫生产业企业管理协会医联体分会会长、首都医科大学附属北京佑安医院院长李宁宣读全国医联体分会肝病医联体成立通知,并为放疗医联体主席、病理医联体主席授予聘书,并发表“互联网+医联体+大数据+(消除肝癌对高危人群健康危害行为计划)”为主题的演讲。

国家卫计委病理质控中心主任、医联体分会病理医联体主席陈杰讲话。陈杰宣读全国医联体分会病理医联体成立通知,并发表“病理诊断在医联体建设中的应用及重要性”为主题的演讲。

北京大学第三医院肿瘤放疗科主任、医联体分会放疗医联体主席王俊杰宣读全国医联体分会放疗医联体暨一带一路肿瘤精准放疗与微创治疗战略发展联盟成立通知,并发表相关主题的演讲。

全国卫生产业企业管理协会医联体分会会长



首都医科大学附属北京佑安医院院长李宁讲话

国家卫计委病理质控中心主任



医联体分会病理医联体主席陈杰讲话



北京大学第三医院肿瘤放疗科主任 “医联体分会放疗医联体”主席王俊杰讲话

武汉大学公共卫生学院副院长、中国卫生信息学会理事宇传华“以基于全病程临床分期和大数据的乙肝相关肝癌精准医疗研究方案”为主题做演讲。最后,北京远程金卫肿瘤医院管理有限公司总裁陈锋上台,以“医联体在肿瘤学科的应用”为主题,将理论与实践结合,使医疗联合体更好服务于疾病,服务于百姓。



武汉大学公共卫生学院副院长 中国卫生信息学会理事宇传华讲话



北京远程金卫肿瘤医院管理有限公司总裁陈锋讲话

此次大会,代表了专科医联体和各专科领域的最高水准,是医联体界的一次精彩华章和饕餮盛宴。我们也期望所有人能够关注、参与和支持全国卫生产业企业管理协会医联体分会的建设和发展,与我们共同推动医联体建设工作在我国健康发展。

医联体不同于以往已规范建立的区域性医联体,属于专门解决各专科领域医疗和学科建设问题的“提高型”医联体,其覆盖范围可以扩展至全国。以上专科医联体的成立,必将为有效解决我国百姓患者的就医问题、探索肿瘤疾病的规范化治疗模式、推动国家肿瘤学科学术的建设与发展起到重大作用。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1982769, encodeId=513e1982e698e, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon May 14 18:08:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223950, encodeId=7c4c22395060, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Jul 19 18:32:05 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335591, encodeId=689f133559159, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Wed Jul 19 03:08:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223264, encodeId=35dd22326461, content=希望癌症治愈, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 17 16:29:18 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223205, encodeId=e19f223205b9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Mon Jul 17 12:54:48 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223197, encodeId=120e22319ec2, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Mon Jul 17 12:32:28 CST 2017, time=2017-07-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1982769, encodeId=513e1982e698e, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon May 14 18:08:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223950, encodeId=7c4c22395060, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Jul 19 18:32:05 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335591, encodeId=689f133559159, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Wed Jul 19 03:08:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223264, encodeId=35dd22326461, content=希望癌症治愈, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 17 16:29:18 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223205, encodeId=e19f223205b9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Mon Jul 17 12:54:48 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223197, encodeId=120e22319ec2, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Mon Jul 17 12:32:28 CST 2017, time=2017-07-17, status=1, ipAttribution=)]
    2017-07-19 往日如昨

    学习了谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1982769, encodeId=513e1982e698e, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon May 14 18:08:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223950, encodeId=7c4c22395060, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Jul 19 18:32:05 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335591, encodeId=689f133559159, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Wed Jul 19 03:08:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223264, encodeId=35dd22326461, content=希望癌症治愈, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 17 16:29:18 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223205, encodeId=e19f223205b9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Mon Jul 17 12:54:48 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223197, encodeId=120e22319ec2, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Mon Jul 17 12:32:28 CST 2017, time=2017-07-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1982769, encodeId=513e1982e698e, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon May 14 18:08:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223950, encodeId=7c4c22395060, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Jul 19 18:32:05 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335591, encodeId=689f133559159, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Wed Jul 19 03:08:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223264, encodeId=35dd22326461, content=希望癌症治愈, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 17 16:29:18 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223205, encodeId=e19f223205b9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Mon Jul 17 12:54:48 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223197, encodeId=120e22319ec2, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Mon Jul 17 12:32:28 CST 2017, time=2017-07-17, status=1, ipAttribution=)]
    2017-07-17 flysky120

    希望癌症治愈

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1982769, encodeId=513e1982e698e, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon May 14 18:08:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223950, encodeId=7c4c22395060, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Jul 19 18:32:05 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335591, encodeId=689f133559159, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Wed Jul 19 03:08:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223264, encodeId=35dd22326461, content=希望癌症治愈, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 17 16:29:18 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223205, encodeId=e19f223205b9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Mon Jul 17 12:54:48 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223197, encodeId=120e22319ec2, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Mon Jul 17 12:32:28 CST 2017, time=2017-07-17, status=1, ipAttribution=)]
    2017-07-17 luominglian113

    学习了,谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1982769, encodeId=513e1982e698e, content=<a href='/topic/show?id=89c4e06902e' target=_blank style='color:#2F92EE;'>#疾病治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70690, encryptionId=89c4e06902e, topicName=疾病治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64f419, createdName=qindq, createdTime=Mon May 14 18:08:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223950, encodeId=7c4c22395060, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Wed Jul 19 18:32:05 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335591, encodeId=689f133559159, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Wed Jul 19 03:08:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223264, encodeId=35dd22326461, content=希望癌症治愈, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Jul 17 16:29:18 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223205, encodeId=e19f223205b9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Mon Jul 17 12:54:48 CST 2017, time=2017-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=223197, encodeId=120e22319ec2, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Mon Jul 17 12:32:28 CST 2017, time=2017-07-17, status=1, ipAttribution=)]
    2017-07-17 中医痴

    不错的,学习了,谢谢分享!

    0

相关资讯

上海:专科医联体“百花竞艳”

记者近日从上海市卫生计生委获悉,该市16个区目前共组建区域医联体40余个,在此基础上,因地制宜、积极探索以专科协作为纽带的专科医联体,包括儿科、妇产科、中医、肿瘤、康复等10多个重点专科,在均衡医疗资源分布、提升区域医疗水平乃至助推分级诊疗等方面,作用明显。

黑龙江省每市至少建成1个“有明显成效”医联体

记者11日从黑龙江省卫计委获悉,今年年内,这个省每所三级公立医院都将牵头组建医联体,每个市(地)至少建成1个有明显成效的医联体。

医联体不是大医院“跑马圈地”双向转诊才是关键

通过医联体建设促进分级诊疗,以实现专家在动、病人不动,让市民能在当地享受到省城专家的医疗服务,才是其应有之义。

如何搭建医联体?盘点全国四种医联体模式

这四种医联体的内容是什么?哪些区域已经形成示范效益?流程如何?各自的优势是什么?又有哪些做得好的案例呢?

海口构建“1+X”紧密型医联体

在近日举行的北京市十二次党代会新闻发布会上,北京市卫生计生委党委书记方来英介绍,京津冀医疗卫生实现全面合作。京津冀三地已陆续签订医政、疾病防控、采供血、卫生应急、综合监督、药品医用耗材集中采购等方面的合作协议,在建立信息共享平台、突发事件协调联动、血液应急调剂等方面取得了积极进展;建成京津冀药品信息数据库,完成了三地药品编码的比对,实现了定期交换药品资质信息及药品价格信息的共享机制。

山东:所有三级公立医院年内启动医联体建设

今年,每个市至少建成2个有明显成效的医联体,三级公立医院全部参与并发挥引领作用;明年,山东省所有县级医院将全部参与医联体建设,并加快向基层医疗卫生机构延伸。这是山东省人民政府办公厅近日印发的《山东省医疗联合体建设推进工作方案》提出的医联体建设工作目标。